Skip to main content

Table 2 Goal and target-population

From: Application of the Gross Motor Function Measure-66 (GMFM-66) in Dutch clinical practice: a survey study

Question

Frequency

Primary purpose

 

 Diagnostic

4/54 (7.4 %)

 Evaluative

46/54 (85.2 %)

 Prognostic

3/54 (5.6 %)

 Else

1/54 (1.9 %)

Secondary purpose(s)

 

 Yes, namely

29/48 (60.4 %)

  Diagnostica

8/34 (23.5 %)

  Evaluativea

6/34 (17.6 %)

  Prognostica

23/34 (67.6 %)

  Elsea

5/34 (14.7 %)

 No

19/48 (39.6 %)

Primary population

 

 Cerebral Palsy

53/53 (100 %)

 Else (e.g. Developmental Coordination Disorder, Neuromuscular disorders, Acquired brain impairment, Rheumatic disorders, Spina Bifida or Down Syndrome)

0/53 (0.0 %)

Secondary population(s)

 

 Yes

32/51 (62.7 %)

  Cerebral Palsya

1/35 (2.9 %)

  Developmental Coordination Disordera

0/35 (0.0 %)

  Neuromuscular disordersa

8/35 (22.9 %)

  Acquired brain impairmenta

18/35 (51.4 %)

  Rheumatic disordersa

1/35 (2.9 %)

  Spina Bifidaa

3/35 (8.6 %)

  Down Syndromea

13/35 (37.1 %)

  Elsea

10/35 (28.6 %)

 No

19/51 (37.3 %)

Primary age category

 

  < 5 months

0/52 (0.0 %)

 5 months – 5 years

19/52 (36.5 %)

 6–11 years

29/52 (55.8 %)

 12–16 years

4/52 (7.7 %)

  > 16 years

0/52 (0.0 %)

Secondary age category

 

 Yes

46/50 (92.0 %)

   < 5 monthsa

1/50 (2.0 %)

  5 months – 5 yearsa

37/50 (74.0 %)

  6–11 yearsa

19/50 (38.0 %)

  12–16 yearsa

24/50 (48.0 %)

   > 16 yearsa

12/50 (24.0 %)

 No

4/50 (8.0 %)

  1. aMultiple answers possible